Abstract
The present study summarizes the biological effects elicit upon A3 adenosine receptor (A3AR) activation in normal and tumor cells. Anti-inflamatory response is mediated upon A3AR activation in neutrophils, eosinophils and macrophages via direct effect on cell degranulation or the production of anti-inflamatory cytokines. In basophils, which highly express A3AR, degranulation and mediator release upon receptor activation lead to pro-inflammatory effects resulting in bronchospasm and asthma. In other normal cells such as cardiomyocytes, neuronal cells and bone marrow cells A3AR activation induces cytoprotective effects in vitro. In vivo, A3AR agonists act as cardio- and neuroprotective agents and attenuate ischemic damage. Furthermore, agonists to A3AR induce granulocyte colony stimulating factor (G-CSF) production and myeloprotective effect in chemotherapy treated mice. Interestingly, A3AR agonists inhibit tumor cell growth both in vitro and in vivo through a cytostatic effect mediated via the de-regulation of the Wnt signaling pathway. The variety of activities elicit by A3AR agonists suggest their potential use as therapeutic agents in inflammation, brain / cardiac ischemia and cancer. Antagonists to A3AR may be implemented to the therapy of asthma and additional allergic conditions.
Keywords: adenosine, adenosine receptor, cancer therapy, myeloprotection, cardioprotection, neuroprotection, antiinflammatory, asthma
Current Topics in Medicinal Chemistry
Title: Pharmacology and Therapeutic Applications of A3 Receptor Subtype
Volume: 3 Issue: 4
Author(s): Pnina Fishman and Sara Bar-Yehuda
Affiliation:
Keywords: adenosine, adenosine receptor, cancer therapy, myeloprotection, cardioprotection, neuroprotection, antiinflammatory, asthma
Abstract: The present study summarizes the biological effects elicit upon A3 adenosine receptor (A3AR) activation in normal and tumor cells. Anti-inflamatory response is mediated upon A3AR activation in neutrophils, eosinophils and macrophages via direct effect on cell degranulation or the production of anti-inflamatory cytokines. In basophils, which highly express A3AR, degranulation and mediator release upon receptor activation lead to pro-inflammatory effects resulting in bronchospasm and asthma. In other normal cells such as cardiomyocytes, neuronal cells and bone marrow cells A3AR activation induces cytoprotective effects in vitro. In vivo, A3AR agonists act as cardio- and neuroprotective agents and attenuate ischemic damage. Furthermore, agonists to A3AR induce granulocyte colony stimulating factor (G-CSF) production and myeloprotective effect in chemotherapy treated mice. Interestingly, A3AR agonists inhibit tumor cell growth both in vitro and in vivo through a cytostatic effect mediated via the de-regulation of the Wnt signaling pathway. The variety of activities elicit by A3AR agonists suggest their potential use as therapeutic agents in inflammation, brain / cardiac ischemia and cancer. Antagonists to A3AR may be implemented to the therapy of asthma and additional allergic conditions.
Export Options
About this article
Cite this article as:
Fishman Pnina and Bar-Yehuda Sara, Pharmacology and Therapeutic Applications of A3 Receptor Subtype, Current Topics in Medicinal Chemistry 2003; 3 (4) . https://dx.doi.org/10.2174/1568026033392147
DOI https://dx.doi.org/10.2174/1568026033392147 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Regulation of Innate Immunity Signaling and its Connection with Human Diseases
Current Drug Targets - Inflammation & Allergy Immunomodulating Properties of Macrolides: Animal and Human Studies
Current Medicinal Chemistry - Anti-Infective Agents Green Synthesis of Silver Nanocomposites of Nigella sativa Seeds Extract for Hepatocellular Carcinoma
Current Nanomaterials Computational Techniques in Fragment Based Drug Discovery
Current Topics in Medicinal Chemistry Treatment of Inflammatory Diseases with Mesenchymal Stem Cells
Inflammation & Allergy - Drug Targets (Discontinued) Subject Index to Volume 2
Current Pharmacogenomics Historical Spice as a Future Drug: Therapeutic Potential of Piperlongumine
Current Pharmaceutical Design Interventions to Prevent Long-Term Consequences of Bronchiolitis
Current Respiratory Medicine Reviews A Review of Recent Patents Concerning Therapy of Respiratory Diseases Using Gene Silencing by RNAi (RISC) and EGS (RNAse P)
Recent Patents on Inflammation & Allergy Drug Discovery Medical Management and Risk Reduction of the Cardiovascular Effects of Underwater Diving
Current Vascular Pharmacology A Purified Fraction of Ocimum tenuiflorum (L) Inhibits LTC4, LTA4 and COX-2 Activities, Down-Regulates mRNA Expression in HL-60 Cells and Reduces Lung Inflammation in an OVA Induced Asthma Model in BALB/c Mice
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Optimized Turmeric Extract Reduces β-Amyloid and Phosphorylated Tau Protein Burden in Alzheimer’s Transgenic Mice
Current Alzheimer Research Derivatization Coupled to Chemiluminescence Detection
Current Analytical Chemistry Medicinal Chemistry of Antimigraine Drugs
Current Medicinal Chemistry Fibrosis as a Therapeutic Target Post-Myocardial Infarction
Current Pharmaceutical Design Potential Biomarkers for Depression Associated with Coronary Artery Disease: A Critical Review
Current Molecular Medicine Itraconazole Induced Congestive Heart Failure, A Case Study
Current Drug Safety Human Disease and Drug Pharmacology, Complex as Real Life
Current Medicinal Chemistry Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review
Reviews on Recent Clinical Trials Role of Biotransformation in Conceptal Toxicity of Drugs and Other Chemicals
Current Pharmaceutical Design